PropertyValue
?:abstract
  • PURPOSE: The role of tracheostomy in COVID-19-related ARDS is unknown. Nowadays, there is no clear indication regarding the timing of tracheostomy in these patients. METHODS: We describe our synergic experience between ENT and ICU Departments at University Hospital of Modena underlining some controversial aspects that would be worth discussing tracheostomies in these patients. During the last 2 weeks, we performed 28 tracheostomies on patients with ARDS due to COVID-19 infection who were treated with IMV. RESULTS: No differences between percutaneous and surgical tracheostomy in terms of timing and no case of team virus infection. CONCLUSION: In our experience, tracheostomy should be performed only in selected patients within 7- and 14-day orotracheal intubation.
?:creator
?:doi
  • 10.1007/s00405-020-05982-0
?:doi
?:journal
  • Eur_Arch_Otorhinolaryngol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/05c045fe5d904657c9814d2264778c6a9c5ad8bf.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7174541.xml.json
?:pmcid
?:pmid
?:pmid
  • 32322959.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC; WHO
?:title
  • Tracheostomy in the COVID-19 pandemic
?:type
?:year
  • 2020-04-22

Metadata

Anon_0  
expand all